Evelyn Andrades

Evelyn Andrades

Auto-generated profile, based on publicly available information

Evelyn Andrades

Group of Inflammatory and Neoplastic Dermatological Diseases, Hospital del Mar Research Institute (HMRIB), 08003 Barcelona, Spain

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2017 in JAMA Dermatology
Verified
Journal Article
Open access
PDF file
IGIgnacio Gómez-Martín
Ignacio Gómez-Martín
SMSara Moreno
Sara Moreno
EAEvelyn Andrades-López
Evelyn Andrades-López
IHInma Hernández-Muñoz
Inma Hernández-Muñoz
FGFernando Gallardo
Fernando Gallardo
SSSonia Segura
Sonia Segura
Pigmented facial macules (PFMs) are commonly evaluated in clinical practice, especially in elderly patients with sun-damaged skin. In this clinical setting, one must distinguish benign PFMs from lentigo maligna (LM) or lentigo maligna melanoma (LMM). Dermoscopy has provided some help in this scenario.1-5 However, some of these lesions exhibit overlapping features,4 and classical dermoscopic LM criteria may not be useful to detect early facial melanomas.

4 August 2022 in BioFactors
Verified
Journal Article
Closed access
EAEvelyn Andrades
Evelyn Andrades
MCMiquel Clarós
Miquel Clarós
JTJuan Vicente Torres
Juan Vicente Torres
LNLara Nonell
Lara Nonell
MGMónica González
Mónica González
AGAna M. M Giménez-Arnau
Ana M. M Giménez-Arnau

9 July 2025 in Allergy
Verified
Journal Article
Open access
DPDavid Pesqué
David Pesqué
EAEvelyn Andrades
Evelyn Andrades
PBPau Berenguer‐Molins
Pau Berenguer‐Molins
JPJúlia Perera‐Bel
Júlia Perera‐Bel
MCMiquel Clarós
Miquel Clarós
AGAna M. M Giménez-Arnau
Ana M. M Giménez-Arnau
Background: Immune mechanisms underlying elicitation in allergic contact dermatitis (ACD) have yet to be fully elucidated. Previous studies have shown a double‐faceted nature of ACD with both common biomarkers among different allergens and allergen‐specific imprinting, albeit with discordance in terms of relevant pathways involved. Several factors, including co‐existing atopic dermatitis, may influence immune reactions. We aim to characterize molecular signatures and their immune mechanisms of different relevant allergens (nickel, 2‐hydroxyethylmethacrylate [2‐HEMA], methylisothiazolinone [MIT], formaldehyde) in strong and extreme positive (2/3+) patch test reactions of patients without atopic dermatitis. Methods: A transcriptomic analysis of 40 skin biopsies of ACD reactions (11 nickel, 10 MIT, 10 2‐HEMA, 9 formaldehyde) and 19 controls (petrolatum‐occluded skin) was performed using RNA sequencing. Differentially expressed genes (DEG) were assessed, and enriched functional pathways were obtained with an over‐representation analysis for allergens. Results: ACD molecular profiling revealed a strong, common imprinting of DEG among allergens versus controls ( n = 814), with further partially shared DEG among allergens ( n = 664) and allergen‐specific DEG ( n = 430). The most relevant shared pathways were associated with immune adaptive and innate responses. All allergens exhibited mixed effector immune responses, mainly type 1 and 3 immunity, and, to a lesser extent, type 2 immunity. Furthermore, partially shared and unique DEG were associated with further inflammatory pathways, particularly for nickel and 2‐HEMA. Conclusions: This study confirms shared ACD imprinting among different allergens and shared pathways' predominant role in ACD elicitation in patients without atopic dermatitis, alongside allergen‐specific immune processes and mixed effector responses (type 1, 3 and 2).

22 October 2025 in Acta Dermato-Venereologica
Verified
Journal Article
Open access
PDF file
DPDavid Pesqué
David Pesqué
PTPaloma Torros-Bosó
Paloma Torros-Bosó
EAEvelyn Andrades
Evelyn Andrades
RPRamòn María Pujol
Ramòn María Pujol
FGFernando Gallardo
Fernando Gallardo
AGAna M. M Giménez-Arnau
Ana M. M Giménez-Arnau
Contact urticaria syndrome, encompassing immunological contact urticaria and protein contact dermatitis, comprises immediate cutaneous reactions with potential systemic manifestations, including anaphylaxis. These conditions are frequently underdiagnosed despite their significant occupational impact. This study aimed to evaluate the clinical and laboratory features associated with distinct phenotypes of contact urticaria syndrome. A retrospective, observational analysis was performed at Hospital del Mar (Barcelona) from January 2010 to January 2024, including adult patients diagnosed with immunological contact urticaria and/or protein contact dermatitis and a positive prick test. Demographic data, clinical data, and complementary test results, including culprit agents, were compared between patients with isolated contact urticaria and those with protein contact dermatitis. A total of 95 patients were included. Results indicated that isolated contact urticaria was more frequently associated with facial involvement (n = 19, 28.8%) and a higher rate of systemic reactions (n = 18, 27.3%), including anaphylaxis, whereas protein contact dermatitis was frequently occupational-related (n = 19, 65.5%), and with a trend toward higher atopic dermatitis comorbidity (n = 12, 41.4%). These findings emphasize the heterogeneity of contact urticaria syndrome and underscore the importance of comprehensive clinical evaluation for effective diagnosis and management.

2 February 2023 in Life Science Alliance
Verified
Journal Article
Open access
PDF file
EAEvelyn Andrades
Evelyn Andrades
ATAgustí Toll
Agustí Toll
GDGustavo Deza
Gustavo Deza
SSSonia Segura
Sonia Segura
RGRamón Gimeno
Ramón Gimeno
IHInmaculada Hernández-Muñoz
Inmaculada Hernández-Muñoz
The initial dissemination of cancer cells from many primary tumors implies intravasation to lymphatic nodes or blood vessels. To investigate the mechanisms involved, we analyzed the expression of small non-coding RNAs in cutaneous squamous cell carcinoma (cSCC), a prevalent tumor that mainly spreads to lymph nodes. We report the reduced expression of small nucleolar RNAs in primary cSCCs that metastasized when compared to non-metastasizing cSCCs, and the progressive loss of DKC1 (dyskerin, which stabilizes the small nucleolar RNAs) along the metastasis. DKC1 depletion in cSCC cells triggered lipid metabolism by altering the mevalonate pathway and the acquisition of metastatic traits. Treatment of DKC1-depleted cells with simvastatin, an inhibitor of the mevalonate pathway, blocked the expression of proteins involved in the epithelial-to-mesenchymal transition. Consistently, the expression of the enzyme 3-hydroxy-3-methylglutaryl-CoA synthase 1 was associated with pathological features of high metastatic risk in cSCC patients. Our data underpin the relevance of the mevalonate metabolism in metastatic dissemination and pave the possible incorporation of therapeutic approaches among the antineoplastic drugs used in routine patient care.

13 August 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
ICIrene Cuervas
Irene Cuervas
SBSophie Bonnal
Sophie Bonnal
EAEvelyn Andrades
Evelyn Andrades
SMSilvia Mateo-Lozano
Silvia Mateo-Lozano
MSMaría Sánchez-Jiménez
María Sánchez-Jiménez
IHInmaculada Hernández-Muñoz
Inmaculada Hernández-Muñoz
Ewing Sarcoma (ES) is an aggressive neoplasm arising in bones and soft tissues driven by the oncogenic fusion EWSR1::FLI1. Through epigenetic deregulation, EWSR1::FLI1 generates de novo super-enhancers that control the expression of key genes for tumor cell maintenance. By an integrative in silico analysis, we identified the subunit of the Mediator complex MED13L and RERE, a member of the atrophin family of arginine-glutamic acid dipeptide repeat-containing proteins, as genes regulated by EWSR1::FLI1-bound super-enhancers. We confirmed that EWSR1::FLI1 regulates MED13L and RERE expression in ES cell lines and showed that these proteins are highly expressed in Ewing primary tumors. Besides the well-established role of the Mediator complex in transcriptional regulation given its association with the RNA polymerase II, in ES cells the DNA binding sites of MED13L overlap with those of RERE and EWSR1::FLI1 in genes that control protein translation and alternative splicing (AS). Accordingly, the expression of various spliceosome components is co-regulated by MED13L, RERE and the oncogene, leading to AS in ES cells. We identified RBM39, a splicing factor downregulated after MED13L and RERE depletion, as a direct transcriptional target of EWSR1::FLI1. Consistently, in vitro viability experiments using indisulam, which induces selective DCAF15-dependent proteosome degradation of RBM39, demonstrate ES cells highly and specifically sensitive to RBM39 inhibition. In vivo experiments with mice xenografted with ES cells show complete tumor regression with indisulam, highlighting the potential of this approach as a novel and promising therapeutic strategy for Ewing sarcoma. STATEMENT OF SIGNIFICANCE: Ewing sarcoma (ES) is characterized by FET::ETS oncoproteins that act as pioneer transcription factors. Here, we identified two genes controlled by EWSR1::FLI1-bound super-enhancers, MED13L and RERE, and characterized the mechanism by which these proteins cooperate with the oncogene to regulate RNA metabolism and ribosomal processes in ES cells. These findings have led to the identification of the splicing factor RBM39 as a vulnerability in ES, as supported by the extraordinary sensitivity of these tumors to monotherapy with RBM39 degrader indisulam.